Suppr超能文献

切入要点:静脉药物使用者感染性心内膜炎的手术治疗观点。

Making the Cut: Perspectives on the Surgical Management of Infective Endocarditis Among People Who Use Intravenous Drugs.

机构信息

Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.

Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

出版信息

Can J Cardiol. 2019 Oct;35(10):1416-1418. doi: 10.1016/j.cjca.2019.05.016. Epub 2019 May 20.

Abstract

In this article we review the perspectives in the literature around surgical treatment for infective endocarditis (IE) in people who use intravenous drugs (PUID). PUID are at increased risk for IE; however, controversy exists regarding how to best manage these patients. We explore the outcomes for surgical treatment in PUID with IE, contrasting these with patients with IE who do not use drugs. We describe some of the perspectives in the literature around second valve replacement for PUID with IE, arguing that moralistic arguments are not on the basis of evidence and perpetuate the stigma experienced by PUID who seek treatment for IE. Finally, we explore the role of substance use interventions in the treatment of PUID with IE, and advocate for further evidence. PUID with IE are a highly stigmatized patient subgroup for whom best practice management strategies are not always implemented, emphasizing the need for further research and advocacy.

摘要

在本文中,我们回顾了文献中关于静脉注射药物使用者(IDU)感染性心内膜炎(IE)手术治疗的观点。IDU 患 IE 的风险增加;然而,对于如何最好地管理这些患者存在争议。我们探讨了 IDU 合并 IE 患者手术治疗的结果,并将其与不使用药物的 IE 患者进行了对比。我们描述了文献中关于 IDU 合并 IE 再次换瓣的一些观点,认为道德主义的论点没有证据支持,并使寻求 IE 治疗的 IDU 患者继续受到污名化。最后,我们探讨了物质使用干预在 IDU 合并 IE 治疗中的作用,并提倡进一步的证据。IDU 合并 IE 是一个高度污名化的患者亚组,对于他们,并非总是实施最佳的治疗管理策略,这强调了进一步研究和倡导的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验